Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma
Overview of attention for article published in Journal of Clinical Oncology, March 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (84th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)
Readers on
- mendeley
- 77 Mendeley